Table 3.
Variables | Person Year | Pneumonia Patients | Incidence Rate (per 100,000) |
---|---|---|---|
Non-ICS user | 87,517.00 | 5432 | 6206.79 |
ICS user | 83,919.32 | 7473 | 8904.98 |
ICS cumulative dose (μg) | |||
1–15,000 | 22,396.12 | 1659 | 7407.53 |
15,000–30,720 | 18,486.25 | 1387 | 7502.87 |
30,721–107,160 | 20,264.26 | 1900 | 9376.11 |
> 107,610 | 22,772.68 | 2527 | 11,096.63 |
ICS dose | |||
Low | 48,189.90 | 4227 | 8771.55 |
Medium | 30,602.72 | 2793 | 9126.64 |
High | 5126.70 | 453 | 8836.10 |
Type of ICS | |||
Fluticasone propionate | 49,698.20 | 4689 | 9434.95 |
Budesonide | 21,076.88 | 1605 | 7614.98 |
Beclomethasone | 6139.31 | 515 | 8388.57 |
Ciclesonide | 3902.04 | 283 | 7252.61 |
Fluticasone furoate | 3102.88 | 381 | 12,278.90 |
Abbreviation: ICS, inhaled corticosteroid.